Sponsors eye Bausch + Lomb carve-out opportunity 

Some PE firms are looking into buying the optical-health subsidiary from Bausch Health and then turning around and reviewing the portfolio for possible divestiture opportunities, some sources said. 

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this